In vivo co-ordinated interactions between inhibitory systems to control glutamate-mediated hippocampal excitability

Journal of Neurochemistry

Volumn 95, Issue 3, 2005, Pages 651-661

  Rodriguez M J ^a   Robledo, P ^a,c   Andrade, C ^a   Mahy, Nicole ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Adenosine; Excitotoxicity; GABA; Glutamate; Microdialysis; Taurine

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE DEAMINASE INHIBITOR; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMIC ACID; GLUTAMINE; POTASSIUM CHLORIDE; TAURINE; URIC ACID;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DEAFFERENTATION; EXCITOTOXICITY; GABAERGIC SYSTEM; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MICRODIALYSIS; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADAPTATION, PHYSIOLOGICAL; ADENOSINE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; DENERVATION; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; MALE; MUSCARINIC ANTAGONISTS; MUSCIMOL; NEURAL INHIBITION; QUINUCLIDINYL BENZILATE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SEPTAL NUCLEI; SYNAPTIC TRANSMISSION; TAURINE; TRITIUM;

ANIMALIA;

EID: 27644474134     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03394.x     Document Type: Article

References (57)

1. Andresen B. T., Gillespie D. G., Mi Z., Dubey R. K. and Jackson E. K. (1999) Role of adenosine A(1) receptors in modulating extracellular adenosine levels. J. Pharm. Exp. Ther. 291, 76-80.
2. Arundine M. and Tymianski M. (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. CMLS Cell Mol. Life Sci. 61, 657-668.
3. Ballarín M., Fredholm B. B., Ambrosio S. and Mahy N. (1991) Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol. Scand. 142, 97-103.
4. Ballarín M., Reiriz J., Ambrosio S. and Mahy N. (1995) Effect of locally infused 2-chloroadenosine, an A1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum. Neurosci. Lett. 185, 29-32.
5. 2 antagonist, on neurotransmission and transduccion systems in the gerbil hippocampus. Brain Res. 646, 211-216.
6. Beaton J. A., Stemsrud K. and Monaghan D. T. (1992) Identification of a novel N-methyl-D-aspartate receptor population in the rat medial thalamus. J. Neurochem. 59, 754-757.
7. Boatell M. L., Bendahan G. and Mahy N. (1995) Time-related cortical amino acid changes after basal forebrain lesion: a microdialysis study. J. Neurochem. 64, 285-291.
8. Britton P., Whitton P. S., Fowler L. J. and Bowery N. G. (1996) Tetanus toxin-induced effects on extracellular amino acid levels in rat hippocampus: an in vivo microdialysis study. J. Neurochem. 67, 324-329.
9. 2A receptor blockade. Purinergic Signalling 1, 111-134.
10. Dunwiddie T. V. and Masino S. A. (2001) The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24, 31-55.
11. Fastbom J., Pazos A. and Palacios J. M. (1987) The distribution of adenosine A1 receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience 22, 813-826.
12. Floderus S. (1944) Untersuchungen über den Bau der Menschlichen Hypophise mit besonderer Berucksichtigung der qualitativen mikromorphologischen Verhältnisse. Acta Pathol. Microbiol. Scand. 53, 1-276.
13. Freund T. F. and Buzsáki G. (1996) Interneurons of the hippocampus. Hippocampus 6, 347-470.
14. García O. and Massieu L. (2003) Glutamate uptake inhibitor 1-transpyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitocondrial toxin 3-nitropropionate: involvement of mitocondrial reducing activity and ATP production. J. Neurosci. Res. 74, 956-966.
15. Ginsberg S. D., Rothstein J. D., Price D. L. and Martin L. J. (1996) Fimbria-fornix transections selectively down-regulate subtypes of glutamate transport and glutamate receptor proteins in septum and hippocampus. J. Neurochem. 67, 1208-1216.
16. Gorovits R., Avidan N., Avisar N., Shaked I. and Vardimon L. (1997) Glutamine synthetase protects against neuronal degeneration in injured retinal tissue. Proc. Natl Acad. Sci. USA 94, 7024-7029.
17. Haberg A., Qu H., Haraldseth O., Unsgard G. and Sonnewald U. (2000) In vivo effects of adenosine A1 receptor agonist and antagonist on neuronal and astrocytic intermediary metabolism studied with ex vivo 13C NMR spectroscopy. J. Neurochem. 74, 327-333.
18. Herrera D. G., Maysinger D. and Goiny M. (1993) Induction of c-FOS immunoreactivity in the hippocampus following potassium stimulation. Neuroscience 52, 237-244.
19. + in rat hippocampus. Brain Res. 658, 39-48.
20. Katayama Y., Maeda T., Koshinaga M., Kawamata T. and Tsubokawa T. (1995) Role of excitatory amino acid-mediated ionic fluxes in traumatic brain injury. Brain Pathol. 5, 427-435.
21. Koelle G. G. and Friedenwald J. S. (1949) A histochemical method for localizing cholinesterase activity. Proc. Natl Acad. Sci. USA 70, 617-622.
22. Louzada P. R., Lima A. C. P., Mendonça-Silva D., Noël F., de Mello F. G. and Ferreira S. T. (2004) Taurine prevents the neurotoxicity of β-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. FASEB J. 18, 511-518.
23. Lucchi R., Latini S., de Mendonça A., Sebastiao A. M. and Ribeiro J. A. (1996) Adenosine by activating A1 receptors prevents GABA A-mediated actions during hypoxia in the rat hippocampus. Brain Res. 732, 261-266.
24. Mahy N., Bendahan G., Boatell M. L., Bjelke B., Tinner B., Olson L. and Fuxe K. (1995) Differential brain area vulnerability to long-term subcortical excitotoxic lesions. Neuroscience 65, 15-25.
25. Mahy N., Prats A., Riveros A., Andrés N. and Bernal F. (1999) Basal ganglia calcification induced by excitotoxicity: an experimental model characterised by electron microscopy and X-ray microanalysis. Acta Neuropathol. 98, 217-225.
26. Massieu L., Haces M. L., Montiel T. and Hernández-Fonseca K. (2003) Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. Neuroscience 120, 356-387.
27. Matés J. M., Pérez-Gómez C., Nuñez de Castro I., Asenjo M. and Márque Z. J. (2002) Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int. J. Biochem. Cell Biol 34, 439-458.
28. McAlonan G. M., Dawson G. R., Wilkinson L. O., Robbins T. W. and Everitt B. J. (1995) The effects of AMPA-induced lesions of the medial septum and vertical limb nucleus of the diagonal band of Broca on spatial delayed non-matching to sample and spatial learning in the water maze. Eur. J. Neurosci. 7, 1034-1049.
29. Mori M., Gähwiler B. H. and Gerber U. (2002) β-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. J. Physiol. 539, 191-200.
30. Nagasawa H., Araki T. and Kogure K. (1994) Alteration of muscarinic acetilcholine binding sites in the post-ischemic brain areas of the rat using in vitro autoradiography. J. Neurol. Sci. 121, 27-31.
31. Nicotera P., Leist M. and Manzo L. (1999) Neuronal cell death: a demise with different shapes. Trends Pharmacol. Sci. 20, 46-51.
32. Nitsch C. and Scotti A. L. (1992) Ibotenic acid-induced calcium deposits in rat substantia nigra. Ultrastructure of their time-dependent formation. Acta Neuropathol. 85, 55-70.
33. A subclass of GABA receptors. J. Neurochem. 74, 2087-2093.
34. O'Regan M. H., Simpson R. E., Perkins L. M. and Phillis J. W. (1992) Adenosine receptor agonists inhibit the release of γ-aminobutyric acid (GABA) from the ischemic cerebral cortex. Brain Res. 582, 22-26.
35. Obrenovitch T. P. and Urenjak J. (1997) Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog. Neurobiol. 51, 39-87.
36. Obrenovitch T. P., Urenjak J., Zilkha E. and Jay T. M. (2000) Excitotoxicity in neurological disorders - the glutamate paradox. Int. J. Dev. Neurosci. 18, 281-287.
37. Okada M., Katawa Y., Murakami T., Wada K., Mizuno K. and Kaneko S. (1999) Interaction between purinoceptor subtypes on hippocampal serotoninergic transmission using in vivo microdialysis. Neuropharmacology 38, 707-715.
38. Paban V., Jaffard M., Chambon C., Malafosse M. and Alescio-Lautier B. (2005) Time course of behavioral changes following basal forebrain cholinergic damage in rats: environmental enrichment as a therapeutic intervention. Neuroscience 132, 13-23.
39. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
40. Pearson T., Currie A. J., Etherington L. A., Gadalla A. E., Damian K., Llaudet E., Dale N. and Frenguelli B. (2004) Plasticity of purine release during cerebral ischemia: clinical implications? J. Cell Mol. Med. 7, 362-375.
41. Petegnief V., Saura J., Dewar D., Cummins D. J., Dragunow M. and Mahy N. (1999) Long-term effects of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoyl-benzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions. Neuroscience 94, 105-115.
42. Ramonet D., Rodríguez M. J., Fredriksson K., Bernal F. and Mahy N. (2004) In vivo neuroprotective adaptation of the glutamate/glutamine cycle to neuronal death. Hippocampus 14, 586-594.
43. Robledo P., Ursu G. and Mahy N. (1999) Effects of adenosine and γ-aminobutyric acid A receptor antagonists on N-methyl-D-aspartate induced neurotoxicity in the rat hippocampus. Hippocampus 9, 527-533.
44. Rodríguez M. J., Martinez-Sánchez M., Bernal F. and Mahy N. (2004) Heterogeneity between hippocampal and septal astroglia as a contributing factor to differential in vivo AMPA excitotoxicity. J. Neurosci. Res. 77, 344-353.
45. Rodríguez M. J., Ursu G., Bernal F., Cusi V. and Many N. (2001) Perinatal human hypoxia-ischemia vulnerability correlates with brain calcification. Neurobiol. Dis. 8, 59-68.
46. Sapolsky R. M. (2001) Cellular defenses against excitotoxic insults. J. Neurochem. 76, 1601-1611.
47. Saransaari P. and Oja S. S. (1997) Enhanced GABA release in cell-damaging conditions in the adult and developing mouse hippocampus. Int. J. Dev. Neurosci. 15, 163-174.
48. Saransaari P. and Oja S. S. (2004) Charateristics of taurine release induced by free radicals in mouse hippocampal slices. Amino Acids 26, 91-98.
49. Saura J., Boatell M. L., Bendahan G. and Mahy N. (1995) Calcium deposits formation and glial reaction in rat brain after ibotenic acid-induced basal forebrain lesions. Eur. J. Neurosci. 7, 1569-1578.
50. Schliebs R., Liebmann A., Bhattacharya S. K., Kumar A., Ghosal S. and Bigl V. (1997) Systemic administration of defined extracts from Withania somnifera (Indian gingseng) and shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem. Int. 30, 181-190.
51. Simpson R. E., O'Regan M. H., Perkins L. M. and Phillis J. W. (1992) Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists. J. Neurochem. 58, 1683-1690.
52. 2A receptors. Prog. Neurobiol. 59, 355-396.
53. Venero J. and Hefti F. (1998) Regional specific induction of BDNF and truncated trkB.Tl receptors in the hippocampal formation after intraseptal injection of kainic acid. Brain Res. 790, 270-277.
54. Waite J. J., Chen A. D., Wardlow M. L. and Thai L. J. (1994) Behavioural and biochemical consequences of combined lesions of the medial septum/diagonal band and nucleus basalis in the rat when ibotenic acid, quisqualic acid and AMPA are used. Exp. Neurol. 30, 214-229.
55. Yu Z. F., Bruce-Keller J., Goodman Y. and Mattson M. P. (1998) Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J. Neurosci. Res. 53, 613-625.
56. Zapata A., Capdevila J. L. and Trullás R. (1998) Region-specific and calcium dependent increase in dyalisate choline levels by NMDA. J. Neurosci. 18, 3597-3605.
57. Zapata A., Capdevila J. L. and Trullás R. (2000) Role of high-affinity choline uptake on extracellular choline and acetylcholine evoked by NMDA. Synapse 35, 272-280.